Success Stories: A Vietnamese Dean in Molecular Biology Gets NIW Approval in Just 4 Months and 24 Days, Thanks to Her Immense Publication Record and Our Team’s Help
Client’s Testimonial:
“Thank you very much for your help!”
On May 28th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Dean in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Dean
Country of Origin: Vietnam
Country of Residence at the Time of Filing: Vietnam
Approval Notice Date: May 28th, 2022
Processing Time: 4 months, 24 days
Case Summary:
Whenever we receive requests to file any kind of petition for a client, we make sure to use customization as a tool to give a particular advantage to the client depending on their cases. This usually requires us to go through their academic and professional documents and collect data such as their publication history or citation count, the number of recommending experts, and so on. In particular, the publication history serves as an important marker in determining the client’s expertise in any chosen area.
So, when we received a request for an NIW (National Interest Waiver) petition from an expert in molecular biology, we made sure to look at her publication count. It was soon evident that she was a valuable member of the scientific community as we discovered that her research has resulted in 43 peer-reviewed journal articles (1 of them first-authored), 10 conference articles, 1 book chapter, and 5 books. She is also listed as a corresponding author for her 52 total peer-reviewed journal and conference articles. Not only this but her work had also been cited a total of 202 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of molecular biology.
We were soon able to conclude that her work was of great importance because it is advancing screening, diagnostic, and treatment processes for many types of cancer, including breast cancer. Considering that the World Health Organization (WHO) reports that about 685,000 women died from breast cancer in 2020 worldwide, her work takes on new significance globally. This is why one of her 4 recommenders said:
“[Client’s] research on molecular diagnosis provides a mechanism for improving the United States' response to upcoming global health threats like coronavirus by improving diagnosis and treatment times, thus limiting the damage inflicted by future pandemics. Hence, her research efforts are crucial to the public health in this country, as well as to protecting the economy from long-term damage as a result of viral infections.”
At the same time, she has completed at least 6 reviews to date and her study has received funding from the National Foundation for Science and Technology Development and the Ministry of Education and Training in Vietnam. Her 17 years of work in the field have thus yielded a formidable scientific output both academically and otherwise. Her work was appreciated by another expert in the following words:
“[The client] continues to pursue important research that provides important fundamental data for other researchers to build upon in their own work. Her findings as described herein have inspired significant discussion in the field and have served as important foundational work in many respects. Scientists with the willingness to challenge long-held beliefs are a key asset to the scientific community, and this is especially true in the United States as the nation seeks to maintain its scientific edge in the global community.”
Thus, it was evident that her work was needed for the United States to win her the approval in less than 5 months. We are glad to have had the opportunity to help her in the process and we wish her all the best in her future endeavors.